Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1209 per ML under NDC 00378920535. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on Sep 12, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/10mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378920535
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212913FDA Approved
9/12/2022
TE Code
AB
On Market Since
9/22/2022
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 62.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1209 per ML |
|---|---|
| All-time high | $0.3838 (Oct 11, 2023) |
| All-time low | $0.1153 (Jul 22, 2026) |
| 52-week high | $0.1253 |
| 52-week low | $0.1153 |
| Median price | $0.2368 |
| Average price | $0.2330 |
| Largest weekly change | +53.6% (Jun 19, 2024) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sucralfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Mylan Pharmaceuticals Inc., is $0.1209 per ML (NDC 00378920535), effective Aug 19, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 62.5%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Nov 9, 2022, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.3838 (Oct 11, 2023), with a median of $0.2368 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SUCRALFATE 1 GM/10 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 00378920535) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.